TY - JOUR
T1 - Disfunzione erettile nel paziente cardiopatico
T2 - Diagnosi e raccomandazioni terapeutiche
AU - Gandaglia, Giorgio
AU - Montorsi, Francesco
AU - Montorsi, Piero
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Erectile dysfunction (ED) is common among patients with cardiovascular diseases (CVD). Sexual problems usually precede the onset of CVD and should, therefore, be considered as a risk factor for cardiac events. Similarly, patients with preexisting CVD are at increased risk of experiencing ED. Therefore, ED and CVD might be considered as two different clinical manifestations of the same systemic disease. Moreover, these conditions share many common pathophysiological mechanisms. Patients with preexisting CVD and ED should be stratified according to their cardiovascular risk. Sexual activity is safe in patients at low risk of CVD and these individuals might be treated with pro-erectile medications. On the other hand, men at high risk of CVD should be reassessed and the cardiac condition should be stabilized before they might have sexual attempts. Recent evidence suggests that lifestyle changes, administration of phosphodiesterase type-5 inhibitors, and testosterone supplementation might improve sexual function and reduce the risk of experiencing CVD during follow-up.
AB - Erectile dysfunction (ED) is common among patients with cardiovascular diseases (CVD). Sexual problems usually precede the onset of CVD and should, therefore, be considered as a risk factor for cardiac events. Similarly, patients with preexisting CVD are at increased risk of experiencing ED. Therefore, ED and CVD might be considered as two different clinical manifestations of the same systemic disease. Moreover, these conditions share many common pathophysiological mechanisms. Patients with preexisting CVD and ED should be stratified according to their cardiovascular risk. Sexual activity is safe in patients at low risk of CVD and these individuals might be treated with pro-erectile medications. On the other hand, men at high risk of CVD should be reassessed and the cardiac condition should be stabilized before they might have sexual attempts. Recent evidence suggests that lifestyle changes, administration of phosphodiesterase type-5 inhibitors, and testosterone supplementation might improve sexual function and reduce the risk of experiencing CVD during follow-up.
KW - Androgen levels
KW - Cardiovascular disease
KW - Chronic inflammation
KW - Erectile dysfunction
KW - Phosphodiesterase type-5 inhibitors
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=84979085340&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979085340&partnerID=8YFLogxK
U2 - 10.1714/2252.24262
DO - 10.1714/2252.24262
M3 - Articolo
C2 - 27310909
AN - SCOPUS:84979085340
VL - 17
SP - 356
EP - 362
JO - Giornale Italiano di Cardiologia
JF - Giornale Italiano di Cardiologia
SN - 1827-6806
IS - 5
ER -